As healthcare shifts towards digital, the spotlight is shining on the emerging field of Digital Therapy (DTx). With unique mechanisms of action and proven outcomes, digital therapies have enormous potential. Join this panel of seasoned dealmakers to learn how can BioPharma can participate. Where should R&D reside? What partners are needed and what lessons have we learned so far?
Session ID: 552852